Mirion Technologies Inc (MIR) Receives Outperform Rating
Northland Capital Markets initiates coverage on Mirion Technologies Inc (MIR) with an Outperform rating.
Mirion Technologies, Inc. engages in the provision of radiation safety, science, and medicine. The company is headquartered in Atlanta, Georgia and currently employs 2,860 full-time employees. The company went IPO on 2020-06-29. The firm's segments include Nuclear & Safety and Medical. The Medical includes products and services for radiation therapy, nuclear medicine and personal dosimetry. This segment’s principal product offering is Radiation Therapy Quality Assurance, which includes solutions for calibrating and/or verifying imaging, treatment machine, patient treatment plan, and patient treatment accuracy. The Nuclear & Safety includes products and services focused on addressing critical radiation safety, measurement and analysis applications across nuclear energy, laboratories and research and other industrial markets such as defense. For Nuclear Power Plants (NPPs), it sells products and services for use at any stage of their life (construction, operation, decommissioning and dismantling).
Latest news, analyst ratings, earnings reports, dividends, insider trades, and market analysis for Mirion Technologies Inc.
Last Updated: Dec 11, 2025, 11:38 PM · Source: Finnhub.io